发明授权
US07674453B2 Tumor necrosis factor combined with interferon in demyelinating diseases
失效
肿瘤坏死因子与干扰素联合在脱髓鞘疾病中
- 专利标题： Tumor necrosis factor combined with interferon in demyelinating diseases
- 专利标题（中）： 肿瘤坏死因子与干扰素联合在脱髓鞘疾病中
-
申请号： US10503525申请日： 2003-01-29
-
公开(公告)号： US07674453B2公开(公告)日： 2010-03-09
- 发明人: Giampiero de Luca
- 申请人： Giampiero de Luca
- 申请人地址： CH Aubonne
- 专利权人： Ares Trading SA
- 当前专利权人： Ares Trading SA
- 当前专利权人地址： CH Aubonne
- 代理机构： Saliwanchik, Lloyd & Saliwanchik
- 优先权： EP02100110 20020206
- 国际申请： PCT/EP03/50006 WO 20030129
- 国际公布： WO03/066165 WO 20030814
- 主分类号： A61K45/00
- IPC分类号： A61K45/00 ; A61K38/21 ; A61K39/00 ; A61K38/16
摘要：
The invention relates to the use of an agent having, stimulating or maintaining tumor necrosis factor (TNF) activity, together with an interferon (IFN) for treating and/or preventing demyelinating diseases, in particular multiple sclerosis (MS). The use of a combination of a TNF or a tumor necrosis factor binding protein in combination with an interferon for treating and/or preventing demyelinating diseases is preferred.
公开/授权文献
信息查询
